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Abstract
Background: Several studies have shown that the nose-earlobe-xiphoid distance (NEX) is inadequate to estimate the insertion length
of nasogastric tubes. An alternative approach tested in these studies, which leads to > 90% well-placed nasogastric tubes, used a
corrected calculation of the NEX: (NEX × 0.38696) + 30.37. The primary aim of this study was to determine whether using the
corrected NEX was more successful than the NEX in determining the insertion length. The secondary aim was to investigate the
likelihood to successfully obtain gastric aspirate.Methods:Adult patients in a general hospital (N= 215) needing a nasogastric tube
were randomized to the control (NEX) or intervention group (corrected NEX). Tip positioning was verified using X-ray. Correct
tip positioning was defined as between 3 and 10 cm under the lower esophageal sphincter (LES). Results: In >20% of all patients,
both methods underestimated the required tube length for correct positioning. The NEX showed an overestimation (17.2%) of the
insertion length (>10 cm under the LES) comparedwith the correctedNEX (4.8%). There was no difference (P= 0.938) between the
2 groups in obtaining gastric aspirate (55.6% vs 56%). However, correct tip positioning resulted in a fourfold increase of obtaining
gastric aspirate.Conclusions: Both methods resulted in a high risk of incorrectly placed tubes due to malposition of the tip near the
LES or distal esophagus. This may increase the risk of reflux and pulmonary aspiration. Based on these results, the development
of more reliable methods requires consideration. (Nutr Clin Pract. 2018;00:1–8)
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Introduction
Enteral feeding via nasogastric tube is a frequently used
short-term method for patients who cannot eat or whose
oral nutrition intake is insufficient. In adults, the stomach
is a J-shaped organ with a greater curvature of 34 cm, a
maximum transverse diameter of 10 cm, a pyloric sphincter
diameter of 1.2 cm, and a capacity of 0.9 litres.1 A correct
position of the tip of the nasogastric tube inside the stomach
is required to ensure the safe administration of nutrients.2,3
Correct positioning will also prevent reflux and aspiration
of nutrients into the lungs. An incorrect gastric tip position
due to underestimation of the tube may lead to feeding
remaining in the esophagus because most tubes have several
lateral openings proximal of the distal tip opening. Con-
versely, overestimation (leading to a tube segment located
too deep into the stomach) can cause curling of the tube
inside the stomach or even migrating the tube back into the
esophagus or beyond the pylorus into the duodenum. Incor-
rect positioning may also prevent obtaining an aspirate for
pH measurement or gastric residual volume.4,5
Although pulmonary aspiration is 1 of themost common
complications in enterally fed patients, reliable prevalence
data about aspiration are difficult to determine due to vague
definitions, poor assessment methods, and varying levels of
clinical recognition. Pulmonary aspiration of feeding can
be caused by either pulmonary misplacement of the tube
or incorrect positioning of the tube in the gastrointesti-
nal tract. In 2005, incorrectly placed nasogastric tubes in
general were first recognized in England by the National
Patient Safety Agency (NPSA) as a patient safety issue.
Between September 2005 and March 2010, there were 21
deaths and 79 reported cases in England of harm related
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to feeding through misplaced nasogastric tubes. In 2009,
inadequate feeding related to a misplaced nasogastric tube
became a never event, which is defined as a serious, largely
preventable patient safety incident that should not occur if
the available preventative measures have been implemented
by healthcare providers. Despite all guidance, during 2009–
2010 there were 41 never events reported to the NPSA in
which a misplaced nasogastric tube was not detected prior
to use. Even at this time, misplaced nasogastric tubes are
never events: Between September 2011 and March 2016, a
total of 95 incidents were reported. These incidents show
that, despite the sensitization of all stakeholders, risks to
patient safety persist.6
Most often, the nose–earlobe–xiphoid (NEX) method is
used to determine the insertion length of a nasogastric tube.
This measures the length from the tip of the nose to the
earlobe to the xiphoid.7,8 This simple and popular method
was introduced by Royce, Tepper, Watson, and Day in 1951.
They described a 6-month experience of estimating the
appropriate tube length using external anatomical reference
points in neonates. Subsequently, the NEX method was
recommended as a gold standard for neonates, children,
and adults in nursing textbooks without further research
or reflection. The reliability of the NEX method in both
adults and pediatric populations, however, has been ques-
tioned several times.8-10 Using theNEX, Ziemer and Carroll
noticed that a deeper insertion was often needed to obtain
a gastric aspirate.7
After a study on healthy volunteers and a postmortem
study including 99 cases, Hanson described alternative
formulas to calculate the nasogastric tube length in a more
reliable way.2 Two formulas were proposed as a correction
of the NEX (method 1 and 2), and 1 formula was based on
body length (method 3):
Method 1: ([NEX – 50 cm]/2) + 50 cm
Method 2: (NEX × 0.38696) + 30.37
Method 3: (body length × 0.20239) + 17.07
Method 2 resulted in more nasogastric tubes being
placed correctly inside the stomach (92.3% vs 91.35%), with
a tip position ranging from 1 to 10 cm under the lower
esophageal sphincter (LES) being optimal.2 For that reason,
method 2 was selected as the experimental intervention
in this current randomized controlled trial. Ellett et al
already had reported that the minimum insertion length of
the nasogastric tube corresponds to the distance from the
tip of the nose to the gastroesophageal junction, thereby
adding the distance from the tip of the tube to the most
proximal lateral opening on the tube to ensure that each
lateral opening was located inside the stomach.3 The ac-
tual required length of the nasogastric tube according to
either control or intervention group was determined just
before the placement procedure starting from the distal tip
opening of the tube. To consider a tube as correctly placed
inside the stomach, the presence of the lateral openings
was taken into account (as described in the interventions
and outcomes section of this article). The target popu-
lation of this study were adults because a method for
newborns and children (using the distance between the tip
of the nose to the earlobe to the mid-umbilicus) already
exists.9,10
The primary aim of this first prospective randomized
trial was to determine whether the use of the Hanson
formula (NEX × 0.38696) + 30.37 was more successful
than using the NEX method. The secondary aim was to
investigate the likelihood to obtain a gastric aspirate to
perform pH measurement.
Methods
Study Design
This study was designed as a blinded prospective random-
ized trial. The data were collected between December 2015
and September 2016 in a Belgian general hospital on both
intensive care units (ICU) and non ICUs.
Participants
Patients were eligible to participate if they met the following
criteria: adult (aged  18 years) and a medical indication
for nasogastric tube feeding. Patients were excluded when
the xiphoid was not palpable or if they had documented
surgical or anatomical abnormalities of the esophagus or
stomach (eg, hiatus hernia). Written informed consent was
obtained from all patients or their legal representatives in
case of diminished awareness or coma.
Participants were randomized to either the control or the
intervention group using block randomization.11 Random-
ization was performed by an investigator with no clinical
involvement in the trial. A randomization list with 2 groups
(control and intervention group), block sizes of 6 patients,
and an actual list length of 240 participants (control group
and intervention group) was created.
After assignment to 1 of the study groups, blinding was
performed at the following levels:
Included patients were kept blinded to their allocation.
Data collectors (clinical nutrition nurse specialists) could
not be blinded. They were aware of the allocated arm
to perform the appropriate intervention.
Outcome adjudicators (radiologists) were also kept
blinded to minimize bias and maximize the validity
of the results.
Interventions and Outcomes
Two experienced clinical nutrition nurse specialists indepen-
dently measured the NEX distance (Figure 1) in all patients.
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Figure 1. NEX distance.
NEX, nose-earlobe-xiphoid distance.
The 2 measurements were taken within a short space of
time according to the following procedure: the patient was
in supine position with the chest at an angle of 30° and
facing forward. The chest was uncovered, and the xiphoid
was marked. A measuring tape with an accuracy up to half
a centimeter was directed in a straight line from the tip of
the nose to the earlobe and then to the marked xiphoid
(Figure 1). A nasogastric tube was subsequently inserted.
The nasogastric tube used in the study was a
polyurethane radiopaque feeding tube (Nutricia Flocare
ENFit; CH10 or CH14, total length 110 cm), manufactured
by Danone Trading B.V., Schiphol, The Netherlands and
consisting following characterisitcs: An internal guidewire,
a distal opening in the tip, and lateral openings up to 2 cm
from the distal tip. The guidewire ended 5 cm before the
distal tip opening. Newly placed tubes were inserted by
the 2 clinical nutrition nurse specialists according to the
randomization criteria. If the tubes were already in situ but
not yet used for tube feeding, they were only repositioned
but not replaced, again according to the randomization
criteria. A safety margin of 1 cm was added so a correct
tip position of the nasogastric tube inside the stomach was
defined as somewhere between 3 and 10 cm under the LES.
After insertion or repositioning, the tube was fixed to the
nose with a fixation tape for nasal tubes manufactured by
ConvaTec, Deeside, UK (ConvaTec Naso-Fix).
A gastric aspirate was obtained immediately after inser-
tion or repositioning of the nasogastric tube because pH
measurement is considered an alternative bedside method
to X-ray to check the position of a nasogastric tube.11
A large syringe (60 mL) with an ENFit (Danone Trading
B.V., Schiphol, The Netherlands) connection was used for
aspiration. An initial attempt of obtaining gastric aspirate
occurred before the removal of the guidewire. If no aspirate
could be obtained, an extra attempt was made 1 hour after
Figure 2. Flowchart for evaluating the X-ray images.
Cm, centimeter; VOD, vault of the diaphragm.
removal of the guidewire. Gastric aspirate was tested for pH
using pH color-indicator strips (pH 2.0–9.0) with a 0.5 pH
interval scale (Merck KGaA, Darmstadt, Germany). If an
aspirate could be obtained, a pH value  5.5 indicated that
it was indeed gastric aspirate.12
A chest X-ray of the patient, positioned in supine posi-
tion as described above, was taken in situ to determine the
tip position of the tube. Preferably, the guidewire was left
inside or put back inside the tube to increase the visibility
of the nasogastric tube on X-ray. The chest X-ray images
covered the area from the apex to the base of the lungs,
including the diaphragm and the stomach below. All of the
images were retrieved from the hospital picture archiving
and communication system, processed and anonymized
using DicomCleaner (PixelMed Publishing, Bangor, PA),
and then evaluated on medical imaging monitors.
Instruments
The chest X-ray images were independently evaluated
by 3 different radiologists using a predefined evaluation
flowchart (Figure 2). The authors and the 3 participating
radiologists used the vault of the diaphragm as the reference
point for the location of the LES in the assessment of
the images because the LES itself is not very clear on
an X-ray.
“Obtainment of gastric aspirate” was considered as neg-
ative after 2 attempts (as described above) without retrieving
gastric content within 1 hour after insertion. A few drops of
the aspirate were placed on a pH indicator strip.
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Statistical Methods
Statistical analyses were conducted using SPSS 24.0 (IBM
Corporation, Armonk, NY). Categorical variables were
presented as frequencies (percentages); normally distributed
continuous variables were described using means and stan-
dard deviations (SD); and between-group comparisons were
performed using independent samples t test. Comparison
of categorical data between groups was performed using
χ2 test.
The interobserver agreement between the 3 independent
radiologists was assessed using κ statistics. Observer agree-
ment was defined as 2 or more concurring interpretations
of the X-ray being tip <3 cm under the LES, between 3
and 10 cm under the LES, > 10 cm under the LES, or
tip not visible on X-ray. To obtain an overall κ value of
the assessments, Fleiss κ was calculated. The classification
system used byCoblentz et al was used to define the strength
of agreement for the κ coefficient.13
The association between the study group and the out-
comewas controlled for age, gender, body length, and cogni-
tive awareness using amultivariate logistic binary regression
analysis. The variable “gastric aspirate obtained”was added
to the multivariate model to analyze how this variable was
related to the correct positioning of the nasogastric tube.
Hosmer-Lemeshow statistic was calculated as a measure of
model fit. A significance level of P < 0.05 was applied.
Ethical Statement and Trial Registering
All patients (or their legal representative in case of dimin-
ished awareness or coma) gave informed consent. Collecting
the informed consents was done by the clinical nutrition
nurse specialists. Patients or their representatives who were
unable or unwilling to sign the written informed consent
were excluded from the study.
The study protocol was approved by the Review Com-
mittee for Medical Ethics from AZ Nikolaas (East Flan-
ders, Belgium) (EC15053). The study was registered at
ISRCTN.com (ISRCTN18322407).
Results
Patient Characteristics
A total of 215 patients participated in the study. The quality
of the X-ray images of 32 patients was insufficient to
allow conclusive determination of the position of the tip of
the nasogastric tube. Although the nasogastric tubes were
visible on all X-ray images, the images had poor margin
settings and thus the tip was not visible on the image
and could not be evaluated. Therefore, after the procedure
of taking X-ray images, data of only 183 persons were
used for further analysis: 99 patients were included in the
control group and 84 patients in the intervention group.
Characteristics of the control and intervention group were
comparable (P > 0.05), as shown in Table 1.
Tip Position and Gastric Aspirate
An overall significant difference (P = 0.032) was demon-
strated between the 2 groups regarding the positioning of
the tip. The tip of the nasogastric tube was situated <3 cm
under the LES in 20.2% of the tubes in the control group
and in 22.6% in the intervention group (P = 0.691). A
significant difference (P= 0.009) concerning overestimation
of the tip position was found between the control group
(17.2%) and the intervention group (4.8%). There was
no statistically significant difference (P > 0.05) between
both methods for external length determination and the
chance of successfully obtaining gastric aspirate through
the nasogastric tube. Absolute values, percentages, and P
values are shown in Table 2. The interobserver reliability of
the X-ray evaluation between the 3 radiologists indicated
acceptable agreement (κ = 0.44, 95% confidence interval
[CI], 0.39–0.49).
Figure 3 shows the distribution of the nasogastric tube
insertion lengths using either the NEXmethod or Hanson’s
formula-corrected NEX distance. Using the NEX method,
the mean insertion length was 51.62 cm (SD 3.79) and the
interquartile range (IQR) was 4 with a minimum insertion
length of 40.5 cm and a maximum insertion length of
59.5 cm. Using (NEX × 0.38696) + 30.37, the mean
insertion length was 50.50 cm (SD 1.62) and an IQR of 1.95
with aminimum insertion length of 43.5 cm and amaximum
insertion length of 53.0 cm. The distribution of the insertion
lengths was significantly lower (P = 0.009) using Hanson’s
formula-corrected NEX distance.
Influencing Factors
Five potential influencing factors in aiming for correct gas-
tric tip positioning were analyzed in a multivariate binary
logistic regression analysis: age, gender (male/female), body
length, method of length determination (“NEX”/“(NEX
× 0.38696) + 30.37”) and cognitive awareness level
(aware/diminished awareness/comatose) (Table 3). The
binary outcome variable was “tip position of the nasogastric
tube inside the stomach” (<3 cm under LES = incorrect
position;  3 cm under LES = correct position). The
variables “weight” and “body mass index (BMI)” were not
included in the model due to the large number of missing
values (81 of 183, 44.3%) and their mutual multicollinearity.
The variable “gastric aspirate after placement (yes/no)”
was also included in the model to explore the differences
between the 2 groups concerning this variable. The model
resulted in a significant association (P = 0.001) between
the outcome variable “tip position” and the obtainment
of gastric aspirate (odds ratio 4.109, 95% CI 1.785–9.458).
There is no discrepancy between the model predicted and
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Table 1. Characteristics of Participants (N = 183).a
Characteristics
Control Group
(n = 99)
Intervention Group
(n = 84) P Value
No Data Available
no. (%)
Demographic variables
Age, mean ± SD, years 72.39 ± 12.33 70,62 ± 12.65 0.339
Gender
Male, no. (%)a 52 (52.5) 48 (57.1) 0.532
Female, no. (%)a 47 (47.5) 36 (42.9) 0.532
Clinical variables
Body length, mean ± SD, cm (no.) 165.37 ± 9.09 (97) 164.83 ± 8.22 (84) 0.675 2 (1.1)
Weight, mean ± SD, kg (no.) 70.59 ± 17.99 (61) 66.36 ± 14.52 (41) 0.193 81 (44.2)
BMI, mean ± SD, kg/m² (no.) 25.63 ± 5.74 (61) 24.35 ± 5.01 (41) 0.249 81 (44.2)
Use of antacids, no. (%)b 78 (78.8) 61 (72.6) 0.407 3 (1.6)
Unit
ICU, no. (%)b 50 (50.5) 44 (52.4) 0.800
Non-ICU, no. (%)b 49 (49.5) 40 (47.6) 0.800
Cognitive awareness level
Aware, no. (%)b 43 (43.4) 29 (34.5) 0.219
Diminished awareness, no. (%)b 8 (8.1) 14 (16.7) 0.075
Comatose, no. (%)b 48 (48.5) 41 (48.8) 0.965
BMI, body mass index; ICU, intensive care unit; no., number; SD, standard deviation.
aData collected by clinical nutrition nurse specialists
bPercentages within group
Table 2. Localization of Nasogastric Tubes in Both Groups and Obtainment of Gastric Aspirate (N = 183).
Control Group (n = 99) Intervention Group (n = 84) P Value
Tip positioning
< 3 cm under LES, no. (%) 20 (20.2) 19 (22.6) 0.691
3–10 cm under LES, no. (%) 62 (62.6) 61 (72.6) 0.151
> 10 cm under LES, no. (%) 17 (17.2) 4 (4.8) 0.009
Obtaining gastric aspirate,a no. (%) 55 (55.6) 47 (56.0) 0.938
LES, lower esophageal sphincter; no., number.
aAfter placement of the tube.
the effectively observed probabilities (Hosmer-Lemeshow
2.228, degrees of freedom 8, P = 0.973).
Discussion
This study is the first prospective randomized trial in which
the reliability of the NEX method and Hanson’s formula
has been tested. Both methods are inaccurate when aiming
for a correct tip position of 3 or more cm under the LES.
When using the NEX, the range of tip positions is larger
compared with Hanson’s formula (Figure 3). The chance of
obtaining an aspirate was low (around 56%) in both groups
(Table 2).
One of the key findings from this study was that in both
trial groups in approximately 1 of 5 patients (20.2% in the
control and 22.6% in the intervention group), the tip of the
tube was located <3 cm under the LES. This means that at
least 1 lateral opening of the nasogastric tube was located
in the esophagus or at the same height as the LES. This can
Figure 3. Boxplot describing the distribution of insertion
lengths (in centimeters).
NEX, nose-earlobe-xiphoid distance.
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Table 3. Multivariate Binary Logistic Regression Between Possible Influencing Factors in Aiming for a Correct Tip Position.
β Coefficient Standard Error Wald Statistic df OR (95% CI) P Value
Age −0.007 0.020 0.135 1 0.993 (0.956 – 1.032) 0.714
Gender 0.614 0.555 1.222 1 1.847 (0.622 – 5.481) 0.269
Malea
Female
Body length 0.031 0.035 0.779 1 1.031 (0.963 – 1.103) 0.377
Gastric aspirate 1.413 0.425 11.037 1 4.109 (1.785 – 9.458) 0.001
Yes
Noa
Method of length determination 0.332 0.402 0.684 1 1.394 (0.634 – 3.063) 0.408
NEX
(NEX × 0.38696) + 30.37a
Awareness levela 0.634 2 0.728
Awareness level(1) 0.191 0.442 0.187 1 1.211 (0.509 – 2.883) 0.665
Awareness level(2) 0.542 0.695 0.609 1 1.720 (0.441 – 6.711) 0.435
Constant −4.400 6.438 0.467 1 0.012 0.494
CI, confidence interval; df, degrees of freedom; NEX, nose-earlobe-xiphoid distance; OR, odds ratio.
aReference category.
lead to regurgitation and an increased risk of pulmonary
aspiration.14
The NEX method is the most commonly used technique
for measuring the nasogastric tube length but has been
questioned in the literature.8-10 After a postmortem study
including 99 cases,Hanson concluded that theNEXmethod
resulted in 72% well-placed nasogastric tubes, with the ideal
tip position between 1 and 10 cm under the LES.2 Using
the 2 Hanson formulas adjusting the NEX, the number of
properly placed tubes increased to around 92%; however,
approximately 3% still were located in the distal esophagus,
which was about the same for the NEX (2%). Note that
Hanson’s study did not mention any lateral openings in the
nasogastric tubes, now common in most tubes. Therefore,
the tube must be inserted sufficiently deep into the stomach
to ensure that not only the tip but also all lateral openings
are located inside the stomach to prevent tube feeding
entering the esophagus. In our study, the presence of lateral
openings may explain why the percentage of insufficiently
deep placed nasogastric tubes exceeded Hanson’s. Hanson
also stated that the NEX might lead to an overestimation
of the required length, resulting in a placement >10 cm
under the LES in 25% of cases compared with <6% using
Hanson’s formulas. Our study reached the same conclusion,
with 17.2% of the tubes located >10 cm under the LES in
the control group and 4.8% in the intervention group.
In a study with a cross-sectional design, Ellett et al
tested the reliability of 1 of the formulas proposed by
Hanson (([NEX – 50 cm]/2) + 50 cm) compared with
the NEX.3 A correct tip position was defined as between
3 and 10 cm under the LES. In the NEX group, 9 out
of 21 malpositioned tubes were placed insufficiently deep
vs 11 of 19 tubes in the Hanson group. Additionally,
24 potentially predicting variables were included in the
data collection and analysis in order to develop a new
method for external length determination. This resulted in a
3-variable model of calculation based on gender, weight,
and the distance between nose and umbilicus in supine
position with the head flat (GWNUF), in which gender was
“1” if the participant was male and “0” if the participant
was female: 29.38 + (4.53 × gender) + (0.34 × NUF) –
(0.06 × weight). The GWNUF resulted in 85.3% of correct
positions (vs 72% for the NEX and 84.2% for Hanson)
but here also 5 of 11 malpositioned tubes were in the
esophageal danger zone. In addition to increasing the risk
of feeding in the esophagus due to a malpositioned tip
of the nasogastric tube, the feasibility of the GWNUF in
clinical practice can also be questioned for other reasons: the
difficulty of obtaining the correct weight of bedridden pa-
tients; discomfort for the patients to maintain the required
position; and higher likelihood to make clinical errors when
using different parameters to estimate the insertion length
in clinical practice. The combination of these elements,
together with the large number of included ICU patients
in the study, ensured that this method was not selected as
the preferred intervention in the study. It may not possible
to obtain an accurate weight in critically ill patients who
usually are also ventilated. In addition, the positioning of
ICU patients as described above is not always possible due
to their physical condition.
The study of Boeykens et al. (2014) mainly fo-
cused on pH measurement as an alternative method for
X-ray to confirm the correct position of the nasogastric
tube.12 In Boeykens’ study, the probability of a correctly
placed nasogastric tube was 98.9% when taking pH mea-
surement as criterion. Metheny et al stated that obtaining
Torsy et al 7
gastric aspirate and pH measurement is not useful to detect
placement of the nasogastric tube in the esophagus because
of possible gastric reflux.15,16 Therefore, caution should
be exercised in interpreting a pH measurement on gastric
aspirate. Our study showed that a correctly positioned tip
inside the stomach increased the possibility to obtain gastric
aspirate by almost 4 times. In our study, >20% of all
nasogastric tubes were placed too shallow whether the NEX
or Hanson’s formula was used to determine the insertion
length. Therefore, it is recommended to combine either
method for external length determination with X-ray to
verify correct placement of the tip.
Taylor et al suggested the use of NEX + 10 cm as
an alternative to the NEX method, which would lead to
a reduction from 16% to 7% of misplaced nasogastric
tubes, with the tip located into the esophagus. This small
study (N = 36) using electromagnetic guidance and not
X-ray was solely conducted in an intensive care setting in
a population of mainly neurosurgery and trauma patients
with gastric emptying problems whose stomachs possibly
dilate more than in other patients.5 This method made
it possible to guide the tip of the tube in the stomach
immediately. In earlier studies2,3 as well as in this current
study, an overestimation of the NEX was observed; thus,
theNEX+ 10 cm potentially could result in tubes migrating
postpyloric, curling up/kinking inside the stomach—or even
worse, migrating up and re-entering the esophageal danger
zone.
There are some limitations in this prospective random-
ized trial. Firstly, there was no registration of the number of
excluded patients with previously documented hiatus hernia
during the period of data collection. After including all
patients in the study, there was also a 14.9% patient dropout
due to the poor quality of the chest X-ray images (tube or
tip not visible). Secondly, there was no separate registration
of data obtained by the 2 clinical nutrition nurse specialists
measuring the NEX distances, and thus no conclusions
can be drawn about interrater variability. Finally, the κ
value (κ = 0.44) of the interobserver agreement between the
radiologists can also be questioned. The clinical significance
of this value depends on its context. In a review17 of medical
imaging literature regarding imaging for expressing observer
agreement with regard to categorical data, the conclusion
was made that a κ value  0.4 could be considered an
acceptable level of observer variability. For this reason,
the classification system used by Coblentz at al., in which
agreement is quantified as poor, fair, moderate, good, or
excellent, was followed.13
Despite the fact that Hanson’s formula in our study led
to 72.6% correctly placed nasogastric tubes, with the tip
located somewhere between 3 and 10 cm under the LES,
there were still outliers (both over- and underestimation
of the insertion length) that could not be associated with
any of the variables of the data collection. Despite all,
this study again emphasizes the importance of strict and
clear guidance on preventing potential incidents that may
lead to harm or death. Therefore, further research should
focus on determining other possible influencing factors
(e.g.k anatomical characteristics) for a more correct gastric
tip positioning in order to develop an easy, safe, and
clinically feasible method for estimating the insertion length
of nasogastric tubes.
Conclusions
Both the NEX-method and Hanson’s formula are not reli-
able to determine the appropriate length of the nasogastric
tube in order to obtain a correct tip position between 3
and 10 cm under the LES. At the same time, differences
in the likelihood of obtaining gastric aspirate could not
be demonstrated between the 2 methods. In >20% of
patients, the tip of the nasogastric tube was located in
the esophageal danger zone. To reduce the risk of mis-
placement, and consequently also reduce the inconvenience
caused to patients due to repositioning of the tube, a more
adequate method of determining the appropriate length of
the nasogastric tube should be developed. Meanwhile, it is
strongly recommended to confirm placement of the tube tip
through X-ray and reposition the tube when necessary. This
will minimize the risk of feeding remaining in the esophagus
and of possible reflux.
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